Echo Street Capital Management LLC Bristol Myers Squibb CO Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $641,855 - $728,009	-9,768 Reduced 53.71%	8,417 $583,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $1.25 Million - $1.47 Million	18,185 New	18,185 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $445,236 - $519,041	-8,302 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $491,229 - $575,411	8,302 New	8,302 $491,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $445,937 - $485,626	-7,203 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $289,935 - $326,091	-4,886 Reduced 40.42%	7,203 $455,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $698,018 - $790,983	12,089 New	12,089 $750,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.